Vaping has become a distinct nicotine-use pattern, often involving frequent cue-driven use, rapid reinforcement, stress-based habits, and a sense that the behaviour is easier to repeat than smoking. Hypnosis has begun to attract interest here because it may help with automatic urges, repetitive hand-to-mouth routines, craving responses, and motivation for change.

The most important point from the papers you provided is that the evidence is still thin when the question is specifically hypnosis for stopping vaping. One 2024 paper reports preliminary survey findings from an app-delivered hypnosis intervention aimed at smoking cessation, which suggests that digital hypnosis formats are beginning to be explored in nicotine-related behaviour change. However, this is not the same as a mature evidence base for vaping cessation itself.

By contrast, the broader vaping literature is much stronger when looking at e-cigarettes as aids for quitting smoking. The 2024 Cochrane review found that nicotine e-cigarettes can increase smoking quit rates compared with nicotine replacement therapy, and the 2024 real-world effectiveness paper adds to the view that some popular cessation methods involving vaping may help certain smokers stop combustible tobacco. These findings are relevant to nicotine behaviour change, but they do not directly answer whether hypnosis helps people stop vaping.

That distinction matters. Vaping cessation and smoking cessation overlap, but they are not identical clinical questions. A person trying to stop vaping may already be using nicotine in a different way, may not have a tobacco-smoking history, or may be trying to stop nicotine altogether rather than substitute one form for another. Because of that, the current evidence should be interpreted carefully and not overstated.

The most balanced clinical interpretation is that hypnosis may have a role as a supportive option for people wanting to stop vaping, especially where the problem is driven by habitual urges, stress use, or repetitive behavioural patterns. But at this stage, it is best framed as an emerging area with plausible clinical value rather than a well-established evidence base with clear, settled outcomes.